Investigating the mechanisms underlying resistance to chemotherapy and to CRISPR-Cas9 in cancer cell lines
Crossref DOI link: https://doi.org/10.1038/s41598-024-55138-x
Published Online: 2024-03-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tomasi, Francesca
Pozzi, Matteo
Lauria, Mario
Text and Data Mining valid from 2024-03-05
Version of Record valid from 2024-03-05
Article History
Received: 3 July 2023
Accepted: 20 February 2024
First Online: 5 March 2024
Competing interests
: The authors declare no competing interests.